Answers are grounded in this paper and cite their sources.
Background Most primary prostate cancers (PCa) exhibit a slow and indolent progression that is androgen-dependent. However, a subgroup of advanced prostate cancers has aggressive nature and the ability to cause bone metastasis. Metastatic prostate cancer has a profound immunosuppressive tumor microenvironment, which limits the response to immunotherapy. However, how immune remodeling across bone marrow and prostate tissues contributes to tumor progression and metastatic dissemination remains unclear. Methods We integrated six public single-cell RNA sequencing (scRNA-seq) datasets from 60 individuals, including bone marrow aspirates and prostate cancer–related tissues, to characterize immune cell states, developmental trajectories, and intercellular communication during PCa progression. Functional validation was performed using in vitro experiments and an in vivo subcutaneous xenograft tumor model. Results Immune cells displayed marked heterogeneity between bone marrow and prostate tissues during PCa progression, while bone metastases exhibited a transitional immune phenotype. Correlation analysis identified six immune microenvironment subgroups. Among these, an immune subtype dominated by osteoclast-like macrophages (OLMs) was enriched in primary tumors and associated with poor clinical prognosis. Cell–cell communication analysis computationally predicted a macrophage migration inhibitory factor (MIF)–centered signaling axis linking OLMs with CXCR4 + B cells, accompanied by IL-10 upregulation and reduced recurrence-free survival. Functional assays demonstrated that activated CXCR4 + B cells promote prostate cancer cell proliferation, migration, and invasion via an IL-10–dependent pathway. Pharmacological inhibition of CXCR4 or IL-10 partially reversed these tumor-promoting effects in vitro and in a subcutaneous xenograft model. Conclusions These findings identify a compositionally associated and partially functionally validated immune crosstalk axis, which may promote PCa progression via MIF–IL-10 signaling under experimental conditions.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: